EICHOR
● Active Not Recruiting
PROACTIVE-HF IDE Trial Heart Failure NYHA Class III
Condition: Heart Failure NYHA Class III · Sponsor: Endotronix, Inc.
About this study
This is a prospective, open- label, single arm, multicenter clinical trial to evaluate the safety and effectiveness of the Cordella PA Sensor System in NYHA Class III Heart Failure Patients compared to a Performance Goal (PG).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (74)
| Ascension St Vincent's | Birmingham, Alabama, United States | — |
| Huntsville Hospital | Huntsville, Alabama, United States | — |
| Phoenix Cardiovascular Research Group/Insight | Phoenix, Arizona, United States | — |
| Loma Linda University | Loma Linda, California, United States | — |
| Eisenhower Medical Center | Rancho Mirage, California, United States | — |
| UCSD | San Diego, California, United States | — |
| Kaiser San Francisco | San Francisco, California, United States | — |
| UCSF Medical Center | San Francisco, California, United States | — |
| Kaiser Santa Clara | Santa Clara, California, United States | — |
| South Denver Cardiology | Littleton, Colorado, United States | — |
| Hartford Hospital | Hartford, Connecticut, United States | — |
| Baptist Health South Florida | Miami, Florida, United States | — |
+ 62 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04089059